Health News

Roche Immunotherapy Shows Breakthrough Success in Lung Cancer Clinical Trial

Roche has reported promising results from a late-stage clinical trial of its new immunotherapy drug for advanced lung cancer, marking a significant step forward in cancer treatment.

The study found that patients receiving the immunotherapy experienced notably improved survival rates compared to those on standard treatments, highlighting the growing impact of innovative pharmaceutical research in oncology. Experts say such clinical trial results reinforce the shift toward more targeted and personalized therapies.....

Meet Spanish Exhibitors at - BEAUTYISTANBUL on 7-9 May 2026 in Istanbul, Türkiye!

Spain is a global beauty leader: with over €10.1 billion in cosmetics and perfume exports in 2025, presence in 175 countries, and the position as the world’s second-largest perfume exporter. Spanish beauty stands for innovation, sustainability and excellence —your gateway to competitive and premium quality products worldwide.

Beauty from Spain: Crafted by nature, perfected by innovation, designed for the world. Click to visit....

Pharma Industry Update: FDA Approves New Rare Cancer Drug Under Fast-Track Program

The U.S. Food and Drug Administration (FDA) has approved Partner Therapeutics’ new drug Bizengri for treating adults with a rare form of advanced bile duct cancer. The approval was granted under the FDA’s accelerated fast-track review program, aimed at speeding access to critical therapies for rare diseases.

According to Reuters, Bizengrie, became the first approved treatment for patients with advanced cholangiocarcinoma carrying a rare genetic mutation. Click to visit....

Novo Nordisk Boosts Outlook as Weight-Loss Pill Sales Surge

Danish pharmaceutical giant Novo Nordisk reported stronger-than-expected quarterly profits and raised its 2026 outlook, driven by high demand for its new obesity treatment pill in the United States.

According to Reuters, the company’s oral weight-loss treatment performed better than analysts expected, helping Novo Nordisk strengthen its position in the rapidly growing obesity drug market. The company is competing aggressively with rivals in what analysts predict could become a multi-billion-dollar healthcare sector. Click to visit....

FAQs

• How reliable is Medrasm?

We share evidence-based news reviewed by medical experts.

• Can I trust AI health news?

AI helps spot trends, but our team verifies all findings carefully.

• How often is content updated?

We update stories regularly to keep you informed on the latest healthcare research and medical breakthroughs.

• Are supplements safe to try?

Consult your doctor before starting any new supplement or medication.

• How to subscribe for updates?

Use the subscription box to get news directly in your inbox.